Skip to content
★ Sign in to follow
GW

Geoffrey W. Dr Guy

Président Exécutif
GW Pharmaceuticals PLC
Total declarations
44
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (27 ops.)
€52.9M

Latest filing published 07 May 2021 for GW Pharmaceuticals PLC.

Filing timeline

BuySale
Geoffrey W. Dr Guy

Insider track record

Disclosed buys
0
Disclosed sells
27
Signal history

Geoffrey W. Dr Guy: trading record in brief

All filings by Geoffrey W. Dr Guy on record concern GW Pharmaceuticals PLC, in the capacity of chief executive. We count 44 filings; the first trade dates from 1 March 2019 and the latest from 5 May 2021.

No open-market purchase appears, only 27 sales worth €52.9M. Outside the open market, there are 14 option exercises.

Most recently, on 7 May 2021, the filings show a transaction in GW Pharmaceuticals PLC. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Geoffrey W. Dr Guy

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations43 total

25 of 43 declarations